Awards for November 2016

Federal Awards

Brugarolas, James, NIH, Evaluation of the BAP1 Tumor Suppressor Gene in Renal Cell Carcinoma, $296,932; Cao, Dian, NIH, Autophagy in Metabolic Distress and Cardiac Function: Regulation by the HDAC-FoxO, $132,097; Crandall, Craig, Dept of Defense, Effects of Burn Injuries on Thermoregulatory and Cardiovascular Responses in Sold, $374,776; Dewey, Richard, Massachusetts Genl Hosp/NIH, Phase 3 Trial of Inosine for Parkinson's Disease CCC, $29,764; Gerber, David, Dept of Defense, Phase 0 Trial of Itraconazole for Early-Stage Non-Small Cell Lung Cancer, $209,941; German, Dwight, NIH, Diagnostic and Prognostic Biomarkers for Parkinson’s Disease, $474,765; Goldsmith, Elizabeth, Princeton Univ/DHHS, Multiscale Analysis of Activating Mutations in the RAS Pathway, $37,129;

Greenberg, David, NIH, Gene Silencing Therapeutics for Chronic Infections in Cystic Fibrosis, $366,879; Haley, Robert, Dept of Defense, Neuroepidemiologic Case Definition of Gulf War Illness from Neuroimaging and EEG, $327,534; Haley, Robert, UT Dallas/Dept of Defense, Treatment of Memory Disorders in Gulf War Illness with HDtDCS, $86,540; Hsieh, Jenny, Dept of Defense, Optogenetic Intervention of Post-Traumatic Epilepsy, $121,500; Karp, David, Northrop Grumman/NIH, Northrop Grumman Chair for Ethics Committee, $18,042; Kramer, Helmut, NIH, Genetics of Endocytic Trafficking in the Drosophila Eye, $364,500; Lin, Ken, Washington Univ/NIH, Reproductive Scientist Development Program, $33,750; Lotan, Yair, Univ of Hawaii/NIH, Multiplexed Protein Biomarker Assay for the Detection of Bladder Cancer, $61,590;

Marciano, Denise, NIH, Role of Afadin Signaling in Nephron Tubulogenesis, $345,825; Millner, Lori, Health Resources and Services Admin, Model State-Supported Area Health Education Centers, $94,000; Mitchell, Mack, Cleveland Clinic Fdn/NIH, Novel Therapies in Alcoholic Hepatitis, $243,543; Monson, Nancy, J. Craig Venter Inst/NIH, Somatic Mutations in the Etiology of Multiple Sclerosis, $40,500; Pascual, Juan, NIH, Dietary Treatment of Glut1 Deficiency (G1D), $824,012; Raj, Ganesh (Fellow L. Miao), Dept of Defense, Disruption of the Interaction of the Androgen Receptor with Chromatin, $62,057; Ready, Joseph, Case Western Reserve Univ/NIH, Case GI SPORE-Project 1-Bridge Funding, $66,627; Rosenberg, Roger, Univ of Washington/NIH, NACC Yr 18 Continuation, $26,780; Rosenberg, Roger, Columbia Univ/NIH, Epidemiology of Familial Late-Onset Alzheimer's Disease, $10,000;

Skapek, Stephen, Indiana Univ/NIH, Developmental and Hyperactive Ras Tumor SPORE, $191,192; Smith, Dean, NIH, Aminophospholipid Signaling in Olfactory Transduction, $340,825; Timmerman, Robert, Univ of Maryland/NIH, Investigating Radiation-Induced Injury to Airways and Pulmonary Vasculature, $163,908; Womack, Kyle, Baylor Res Inst/DHHS, North TX Traumatic Brain Injury Model System, $59,175; Yu, Gang, St. Jude Children’s Res Hosp/NIH, Multi-level Integrative Proteomics to Alzheimer’s Disease Pathways, $80,960. 

Non-Federal Awards

Agrawal, Deepak, Cystic Fibrosis Fdn, Developing Innovative GastroEnterology Specialty Training, $32,240; Ahn, Chul, CPRIT, C1: Biostatistical Core, $56,257; Amatruda, James, CPRIT, P3: Functional Validation of Actionable Mutations in Sarcoma Genetic Model Systems, $366,150; Amatruda, James, Dana-Farber Cancer Inst/St. Baldrick’s Fdn, Malignant Germ Cell Tumors International Consortium, $176,839; Amatruda, James, CPRIT, C1: Molecularly Targeted Therapy for Soft Tissue Sarcoma, $166,471; Bachoo, Robert, CPRIT, Acetate May Be a Key Substrate Driving Growth in Early Stage Breast Cancer, $100,000; Bibb, James (Fellow A. Carter), Amer Cancer Soc, Identification of Therapeutic Targets for Neuroendocrine Cancer, $54,000;

Brekken, Rolf, CPRIT, Radiation-Guided Vascular Targeting of Lung Cancer, $285,602; Chen, Elizabeth (Fellow D. Lee), Canadian Inst of Health Res, Investigating Cell-Cell Fusion Mechanism Using Optogenetics, $50,000; Chen, Zhijian, CPRIT, C2: Proteomics Core, $220,214; Chook, Yuh Min, CPRIT, Mechanisms of Nuclear Import and Export in Cancer RP150053, $231,421; De Brabander, Jef, CPRIT, C1: Chemistry and Pharmacology Core, $209,970; Douglas, Peter, CPRIT, Recruitment of Peter M. Douglas, PhD, $500,000; Erzberger, Jan, CPRIT, Erzberger Recruitment of First-Time, Tenure-Track CPRIT, $188,825; Frederick, Kendra, CPRIT, Frederick Recruitment of First-Time, Tenure-Track CPRIT, $164,949;

Fu, Yang-Xin, CPRIT, Recruitment of Established Investigators, $1,204,174; Hon, Gary, CPRIT, Recruitment Award, $469,774; Hsieh, Jer-Tsong, CPRIT, C1: Translational Core, $215,991; Iyengar, Puneeth, Amer Cancer Soc, Unchecked Adipocyte Lipolysis and Tumor Progression in Cachexia, $198,000; Jiang, Steve, CPRIT, Towards Carbon Beam Stereotactic Body Radiation Therapy (C-SBRT), $748,714; Jimenez, Patricia, Washington Univ/Burroughs Wellcome, MSRDP-miRNA Networks During Implantation (BWF), $6,250; Johnson, Jane, CPRIT, Identifying Inhibitors of Ascl1 to Block Growth of Malignant Neuroendocrine, $100,000; Journeycake, Janna, Amer Thrombosis & Hemostasis Network, Transition of Care for Patients with Venous Thromboembolism (VTE) at ATHN Affiliated Sites, $7,500;

Konopka, Genevieve, McDonnell Fdn, Elucidating the Molecular Evolution of Human Cognition, $150,000; Lee, Simon, CPRIT, BSPAN3: Breast Screening and Patient Navigation for Rural and Undeserved, $499,990; Levine, Benjamin, Baylor Univ/NSBRI, STOP VIIP Study: Safe and Effective Countermeasures to Reduce Intracranial Pressure and Ameliorate VIIP in Astronauts, $249,999; Levine, Benjamin, Amer College of Cardiology, N TX Randomized Pilot Study: ECG Screening of Active Young High School Students, $75,000; Luo, Weibo, CPRIT, The Role of Hypoxia-Inducible Factor 1 in Breast Cancer, $500,000; Malloy, Craig, CPRIT, TAMU–UT Southwestern Partnership for Breast Imaging and Spectroscopy at 7 Tesla, $299,358; Mangelsdorf, David, CPRIT, Development of Nuclear Receptors, $56,143; Mason, Ralph, CPRIT, Noninvasive Identification of Prostate Tumor Hypoxia as a Prognostic Biomarker, $299,737;

Mason, Ralph, CPRIT, P3: Effects of Hypoxia, $258,332; Mason, Ralph, Baylor Univ/CPRIT, Targeting Hypoxia in Breast Cancer, $110,475; O'Donnell-Mendell, Kathryn, Sidney Kimmel Fdn, Dissecting Novel Mechanisms of Lung Cancer Pathogenesis, $100,000; Rizo-Rey, Jose, CPRIT, Molecular & Structural Basis of Epigenetic Regulation, $248,374; Rosenbaum, Daniel, David and Lucile Packard Fdn, Structure Determination of Eukaryotic Membrane Proteins, $175,000; Saha, Debabrata, CPRIT, C3: Image Guided Irradiation of Small Animals, $190,931; Scielzo, Shannon, Alliance for Academic Intl Med, Resident Well-Being Assessment System, $5,000; Shearin, Staci, Amer Orthotic and Prosthetic Assoc,  Impact of Carbon Fiber AFOs on Gait and Resulting Changes in Quality of Life Across Time in Persons with PD, $15,000;

Singal, Amit, CPRIT, Implementation of Evidence-Based Colorectal Cancer Screening, $505,299; Skapek, Stephen, UTHSC San Antonio/CPRIT, TX Pediatric Patient Derived Xenograft Facility, $474,008; Skapek, Stephen, CPRIT, P2: HIgh Throughput Screening for Sarcoma Cell Prolifera, $291,286; Skapek, Stephen, CPRIT, AC: Molecularly Targeted Therapy for Soft Tissue Sarcoma, $138,864; Sumpter, Rhea, Burroughs Wellcome Fund, A Novel Role for FANCC in Selective Autophagy, $95,000; Sun, Xiankai, TX Health Presbyt/Rainwater Charitable Fdn, Development of Human Tau Imaging Capability for PSP Research in North TX, $52,338; Terman, Jonathan, Welch Fdn, Chemistry and Enzymology of Mical Family Oxidoreductases, $65,000;

Wang, Richard, Burroughs Wellcome Fund, Akt-Mediated Regulation of Autophagy & Tumorigenesis, $140,000; Westover, Kenneth, CPRIT, Structure-Guided Kinase Inhibitor Design for Cancer Therapy, $300,000; Westover, Kenneth, V Fdn for Cancer Res, Rational Development of GTPase Active Site Inhibitors for Cancer Therapy, $100,000; Xu, Jian, CPRIT, Recruitment Award, $519,489; Yan, Nan, Burroughs Wellcome Fund, STING Activation at the Nexus of Microbial Infection and Host Innate Immunity, $1,000; Yu, Yonghao, Amer Cancer Soc, Overcoming Rapamycin Resistance for the Treatment of Bladder Cancer, $198,000; Zhang, Chengcheng, CPRIT, Novel Targets for Acute Myeloid Leukemia Treatment, $300,000.

Industry Sponsored Awards, dollar amounts not available

AbdelFattah, Kareem, Mediwound, Comparison of NexoBrid and Gel Vehicle for Thermal Burns; Beg, Muhammad, Sillajen, Phase 3 Study of Pexa-Vec with Sorafenib for Advanced Hepatocellular Carcinoma; Beg, Muhammad, Five Prime Therap, Phase 1a/1b Study of FPA008 with Nivolumab for Selected Advanced Cancers; Brugarolas, James, Genentech, Single Cell Genomic Analyses; Frankel, Arthur, Corvus Pharma, Phase 1/1b Study of CPI-444 Alone and with Atezolizumab for Selected Incurable Cancers; Friedman, Deborah, Lilly Research Labs, Phase 3 Study of LY2951742 for Chronic Cluster Headache; Gerber, David, Eli Lilly & Co, Phase 2 Study of LY2606368 for Extensive Stage Disease Small Cell Lung Cancer; Jain, Mamta, Gilead Sciences, Evaluating Access to New Direct Acting Antiviral Treatments among Hepatitis C Patients in Safety Net Hospitals; Laetsch, Theodore, Children’s Hosp Los Angeles, Pilot Study of Vincristine Sulfate Liposome Injection;

Lee, William, Conatus Pharma, Trial of Emricasan for Non-alcoholic Steatohepatitis Fibrosis; Lingvay, Ildiko, Novo Nordisk, Trial  of insulin Degludec/Insulin Aspart vs. Insulin Glargine/Insulin Aspart for Type 2 Diabetes; MacConmara, Malcolm, Transmedics, Portable Organ Care System Liver PROTECT Trial; Miller,David, Tracon Pharma, Phase 2A Study of TRC105 for Refractory Gestational Trophoblastic Neoplasia; Pan, Edward, Bristol-Myers Squibb, Phase 2 Study of Temozolomide for MGMT-Methylated Glioblastoma; Szmuk, Peter, Masimo Corp, Rainbow Acoustic Monitoring (RAM) Clinical Engineering; Torres, Fernando, Bellerophon Pulse Tech, Phase 3 Study of Pulsed, Inhaled Nitric Oxide for Pulmonary Arterial Hypertension: INOvation1; Van Buren, Peter, Akebia Therap, Phase 3 Study of Vadadustat; PRO2TECT.